AngioDefender

DEVICE2 trials

Sponsors

Everist Genomics, Inc

Conditions

Cardiovascular Diseases

Unknown Phase

AngioDefender Versus Brachial Artery Ultrasound Imaging

CompletedNCT02468336

Everist Genomics, IncCardiovascular Diseases

Start: 2015-08-31End: 2017-02-15Updated: 2018-02-01

Vascular Reactivity Assessment by the AngioDefender Device -- A Precision Study

CompletedNCT02641197

Everist Genomics, IncCardiovascular Diseases

Start: 2016-04-06End: 2016-05-19Updated: 2018-02-05

Related Papers

Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer.

2020-09-0126 citations